Business Wire

MORI-ART-MUSEUM

Del
2015.04.25 Mori Art Museum to Reopen after Extensive, Four-month Renovation

The Mori Art Museum , Japan’s leading contemporary art museum located atop Tokyo’s landmark Roppongi Hills Mori Tower, following an extensive four-month upgrade, will reopen on Saturday, April 25 with an exhibition entitled Simple Forms: Contemplating Beauty , Mori Art Museum’s first collaboration with Centre Pompidou-Metz and Fondation d'entreprise Hermès. The exhibition will present the timeless, universal aesthetic of simple forms, from a prehistoric stone implement to dynamic installations by contemporary artists.

Upgrades to the Museum include several technological advancements that will accommodate the growing diversity of artistic expression. Such additions will enable Mori Art Museum to serve as a new model for art museums worldwide by reinforcing its creative, innovative approach to the principle of “Art + Life,” which relates art to all aspects of life for enriched societies.

In addition to staging a wide range of originally-curated exhibitions focused on international and contemporary themes, the Museum will newly launch three smaller program series -- MAM Collection , MAM Screen and MAM Research -- to offer visitors richer and deeper experiences with the diverse world of contemporary art.

In the time since Mori Art Museum opened in 2003, a tide of globalization has swept through the cultural sphere, particularly in art. Contemporary art markets are booming in Asia, and Asian art has established a strong presence at international auctions and art fairs. As global contemporary art becomes more diverse and complex, museums are faced with the challenge of how best to present the great variety, historical context and accessibility of this art form to the public.

Mori Art Museum, based on a revised Mission and Vision that it introduced upon its 10th anniversary and now backed with newly upgraded state-of-the-art facilities, looks forward to expanding its role and direction in the Japanese, Asian and global art scenes as a pioneer of contemporary art.

About the Mori Art Museum, Tokyo

Mori Art Museum opened in 2003 with the aim of becoming a pioneering international museum of contemporary art with special significance for Asia. Grounded in founder Minoru Mori’s firm belief that “culture shapes a city’s identity,” the Museum was opened symbolically on the top floor of Roppongi Hills Mori Tower skyscraper, a noted landmark of Tokyo. The Museum is dedicated to making contemporary art more accessible to all people through a variety of initiatives. For instance, it remains open daily (except Tuesdays) until 10 p.m. during exhibition periods, enabling students and office workers to visit on weeknights after school or work. Now, visitors arriving after 5 p.m. account for 30% of the Museum’s total visitors, which reflects the success of the Museum’s creation and promotion of a new lifestyle. To date, Mori Art Museum has attracted 13.5 million people from around the world, further enhancing its global status as a preeminent museum for contemporary art.

Contact:

Mori Art Museum, Tokyo
Kayo Machino (Ms.)
+81-(0)3-6406-6111
pr@mori.art.museum

Link:

Multimedia Gallery

ClickThru

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

TreeFrog Therapeutics Presents Delivery Strategy for Next Generation 3D Cell Therapy Format for Parkinson’s Disease at the 28th Annual ASGCT Meeting in New Orleans13.5.2025 08:00:00 CEST | Press release

TreeFrog Therapeutics is the first company to present publicly a clinical-ready delivery strategy for 3D format microtissues in cell therapy.After four years in development, the validated device and delivery strategy overcomes challenges of 3D formats and uses existing stereotactic components to support adoption through ease of delivery education. TreeFrog Therapeutics, a French biotech specializing in cell therapy is the first company to present a clinical-ready delivery strategy for 3D microtissues cell therapy. The validated approach was demonstrated for their 3D neural microtissues cell therapy treatment for Parkinson’s disease. Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. It is a progressive disease characterized by the loss of dopaminergic neurons with a mix of motor symptoms (bradykinesia, rigidity, resting tremor) and non-motor symptoms (cognitive deficits, mood disorders, fatigue). Current treatments provide symptomatic re

Ohana Development Launches ‘Jacob & Co. Beachfront Living by Ohana,’ A Masterpiece of Beachfront Elegance in the UAE13.5.2025 08:00:00 CEST | Press release

Valued at USD 1.3 billion, the project offers world-class amenities, including a signature Jacob & Co. ceiling art timepiece, the largest of its kind globally. Ohana Development, the leading real estate developer renowned for its luxury properties, has launched ‘Jacob & Co. Beachfront Living by Ohana’ in partnership with luxury timepiece and jewellery house Jacob & Co. The project was revealed at Emirates Palace Mandarin Oriental, Abu Dhabi. Located in Al Jurf between Dubai and Abu Dhabi, this USD 1.3 billion development blends natural surroundings with exceptional artistry and craftsmanship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512533615/en/ Jacob & Co. Beachfront Living by Ohana. (Photo: AETOSWire) Jacob & Co. Beachfront Living by Ohana presents 457 residences comprising of sea-view apartments, villas, penthouses, Sky Mansions, and beachfront mansions—each capturing the spirit of refined coastal living. Pentho

Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders13.5.2025 07:00:00 CEST | Press release

Financing round led by Jeito Capital and co-led by Forbion Growth, with participation from Seroba, Pictet Group and other existing investorsProceeds to fund two Phase 3 pivotal programs with nizubaglustat, lead asset in Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses as well as expanding the Azafaros pipeline to other indicationsNizubaglustat has been awarded Orphan Drug Designation in both the US and Europe as well as Fast-track status in the US. The company expects to initiate both Phase 3 studies later this year Azafaros, a clinical-stage company focused on developing disease-modifying therapeutics to offer new treatment options to patients with rare lysosomal storage disorders, announces the completion of an oversubscribed €132M Series B financing led by Jeito Capital, co-led by Forbion Growth and with additional participation from Seroba, Pictet Group and existing investors Forbion Ventures, Schroders Capital and BioGeneration Ventures (BGV). This financing enables Az

Presidio Investors is Pleased to Announce the Addition of Christian Schütte as Its Newest Operating Partner12.5.2025 19:04:00 CEST | Press release

Christian brings more than 20 years of global experience in investment banking, private equity, and operational leadership, with a proven track record of driving transformational growth across industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512473756/en/ Christian Schütte Christian began his career at J.P. Morgan in New York and London, where he worked in the M&A and Corporate Finance teams. He later joined Fortress Investment Group and was instrumental in launching its German operations. During his tenure, he helped raise over €1.5 billion in equity and managed a wide array of investments, including non-performing and performing loans, private and public companies. He went on to join EQT Group, where he focused on mid-market growth and succession investments. Notably, he led the consolidation of nine digital marketing agencies into a €100 million market leader, building one of the most comprehensive digital ma

Introducing Joblio – The Future of Ethical Recruitment12.5.2025 18:30:00 CEST | Press release

Joblio Launches to Revolutionize Ethical Recruitment and End Worker Exploitation Joblio, a global ethical recruitment platform, officially launches today to tackle the broken labor migration system—long plagued by exploitative intermediaries, high recruitment fees, and human rights abuses. With its tech-driven model, Joblio connects vetted workers with employers directly, eliminating unethical middlemen and ensuring cost-free hiring for migrant workers. Employers fund access to talent, but workers never pay—a key step in ending exploitation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512628048/en/ A Mission Rooted in Personal Experience Joblio is led by Jon Purizhansky, a refugee-turned-entrepreneur who experienced migration challenges firsthand. Forced to flee his home country as a young man, Jon faced the uncertainty and vulnerability that millions of migrant workers still encounter today. Now a globally recognized

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye